User profiles for David E. Cohen

David E Cohen

- Verified email at med.cornell.edu - Cited by 18865

David E Cohen

- Verified email at nyumc.org - Cited by 9400

Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies

…, JN Bergman, SL Chamlin, DE Cohen… - Journal of the American …, 2014 - Elsevier
Atopic dermatitis is a common and chronic, pruritic inflammatory skin condition that can affect
all age groups. This evidence-based guideline addresses important clinical questions that …

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis

…, TG Berger, JN Bergman, DE Cohen… - Journal of the American …, 2014 - Elsevier
Atopic dermatitis (AD) is a chronic, pruritic, inflammatory dermatosis that affects up to 25% of
children and 2% to 3% of adults. This guideline addresses important clinical questions that …

Regulation of hepatic lipogenesis by the transcription factor XBP1

AH Lee, EF Scapa, DE Cohen, LH Glimcher - Science, 2008 - science.org
Dietary carbohydrates regulate hepatic lipogenesis by controlling the expression of critical
enzymes in glycolytic and lipogenic pathways. We found that the transcription factor XBP1, a …

MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis

…, F Kristo, Y Li, T Shioda, DE Cohen… - Science, 2010 - science.org
Proper coordination of cholesterol biosynthesis and trafficking is essential to human health.
The sterol regulatory element–binding proteins (SREBPs) are key transcription regulators of …

Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents

R Sidbury, DM Davis, DE Cohen, KM Cordoro… - Journal of the American …, 2014 - Elsevier
Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children
and 2% to 3% of adults. This guideline addresses important clinical questions that arise …

[HTML][HTML] Triglyceride metabolism in the liver

M Alves-Bezerra, DE Cohen - Comprehensive physiology, 2017 - ncbi.nlm.nih.gov
Triglyceride molecules represent the major form of storage and transport of fatty acids within
cells and in the plasma. The liver is the central organ for fatty acid metabolism. Fatty acids …

[HTML][HTML] Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

Y Kawano, DE Cohen - Journal of gastroenterology, 2013 - Springer
Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic lipid accumulation in
the absence of excess alcohol intake. NAFLD is the most common chronic liver disease, and …

[BOOK][B] The liver: biology and pathobiology

IM Arias, HJ Alter, JL Boyer, DE Cohen, DA Shafritz… - 2020 - books.google.com
Bridging the gap between basic scientific advances and the understanding of liver disease—the
extensively revised new edition of the premier text in the field. The latest edition of The …

Clinical best practice advice for hepatology and liver transplant providers during the COVID‐19 pandemic: AASLD expert panel consensus statement

…, ML Schilsky, EC Verna, R Loomba, DE Cohen… - …, 2020 - Wiley Online Library
Background and Aims Coronavirus disease 2019 (COVID‐19), the illness caused by the
SARS‐CoV‐2 virus, is rapidly spreading throughout the world. Hospitals and healthcare …

Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease

S Softic, DE Cohen, CR Kahn - Digestive diseases and sciences, 2016 - Springer
Nonalcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome.
Overconsumption of high-fat diet (HFD) and increased intake of sugar-sweetened beverages …